Journals / Epilepsi / 2016 / Cilt: 22 - Sayı: 0

A Patient with Anti-LGI1 Related Autoimmune Limbic Encephalitis who had Frequent and Drug Resistant Seizures

Sık ve Dirençli Nöbetlerle İzlenen Anti-LGI1 İlişkili Otoimmün Limbik Ensefalit Hastası

Journal
Epilepsi
Pages
67–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on this case report, the presenting features, diagnosis and treatment of anti-LGI1 related autoimmune limbic encephalitis are once more stressed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anti-LGI1 auto-antibody related limbic encephalitis is characterized by memory deficits, various neuro-psychiatric symptoms, behavioral disorders and temporal lobe seizures that point to involvement of the limbic system.
📊
Key Findings & Data:A 29-year-old male patient was admitted to our medical center due to long lasting frequent seizures that could not be controlled with four different antiepileptic drugs.
💡
Conclusion & Impact:Based on this case report, the presenting features, diagnosis and treatment of anti-LGI1 related autoimmune limbic encephalitis are once more stressed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Anti-LGI1 auto-antibody related limbic encephalitis is characterized by memory deficits, various neuro-psychiatric symptoms, behavioral disorders and temporal lobe seizures that point to involvement of the limbic system. Neuro-imaging studies reveal abnormal signal intensity in the mesial temporal structures and/or basal ganglia. Seizures are frequently resistant to antiepileptic medications. However they can be dramatically controlled by immunological treatment modalities. A 29-year-old male patient was admitted to our medical center due to long lasting frequent seizures that could not be controlled with four different antiepileptic drugs. However soon after the diagnosis of anti-LGI1 related autoimmune limbic encephalitis, he received IV pulse steroid treatment that lead to complete and rapid cessation of his seizures. Based on this case report, the presenting features, diagnosis and treatment of anti-LGI1 related autoimmune limbic encephalitis are once more stressed.

Özet

Anti-LGI1 otoantikor ilişkili limbik ensefalit hafıza kusuru, çeşitli nöropsikiyatrik semptomlar, davranış bozuklukları ve temporal lob nöbetleri gibi limbik sistemin tutulumuna işaret eden klinik belirtilerle karakterizedir. Nöro-görüntüleme yöntemlerinde mesial temporal yapılar ve/veya bazal ganglionlarda tutulum dikkat çeker. Nöbetler genel olarak antiepileptik ilaçlara dirençlidir. Ancak immün tedavi ile oldukça dramatik bir nöbet kontrolü sağlanabilir. Bu yazıda, merkezimize uzun süreli ve sık nöbetler nedeniyle başvuran 29 yaşında bir erkek hasta sunulmaktadır. Hastanın nöbetleri dörtlü antiepileptik ilaçla kontrol edilemezken, anti-LGI1 ilişkili otoimmün limbik ensefalit olduğunun anlaşılmasından sonra başlanan IV pulse steroid tedavisiyle tam ve hızlı nöbet kontrolü sağlanmıştır. Bu olgu bazında anti-LGI1 ilişkili otoimmün limbik ensefalitin prezentasyonu, tanısı ve tedavisinin bir kez daha vurgulanması amaçlanmıştır.

🔖

Cite This Article

DERİCİOĞLU, N. (2016). A Patient with Anti-LGI1 Related Autoimmune Limbic Encephalitis who had Frequent and Drug Resistant Seizures. Epilepsi, Cilt: 22 - Sayı: 0, 67–71. https://ajindex.com/articles/158363

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9(8):776–85.
  2. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69(5):892–900.
  3. Kaymakamzade B, Kansu T, Tan E, Dericioğlu N. LGI1 related limbic encephalitis and response to immunosuppressive therapy. J Neurol 2011;258(11):2075–7.
  4. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 2010;133(9):2734–48.
  5. Ottman R, Risch N, Hauser WA, Pedley TA, Lee JH, Barker-Cummings C, et al. Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 1995;10(1):56–60.
  6. Chernova OB, Somerville RP, Cowell JK. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998;17(22):2873–81.
  7. Fukata Y, Lovero KL, Iwanaga T, Watanabe A, Yokoi N, Tabuchi K, et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A 2010;107(8):3799–804. Cowell JK. LGI1: from zebrafish to human epilepsy. Prog Brain Res 2014;213:159–79.